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REVIEWViral and vector zoonotic exploitation of a homo-sociome memetic
complexC. E. Rupprecht1,2 and G. W. Burgess3
1) LYSSA LLC, Lawrenceville, GA 30044, 2) The Wistar Institute, Philadelphia, PA, USA and 3) College of Public Health, Medical and Veterinary Sciences,
James Cook University, Townsville, Qld, AustraliaAbstractAs most newly characterized emerging infectious diseases are considered to be zoonotic, a modern pre-eminence ascribed within this
classiﬁcation lies clearly within the viral taxonomic realm. In particular, RNA viruses deserve special concern given their documented
impact on conservation biology, veterinary medicine and public health, with an unprecedented ability to promote an evolutionary
host–pathogen arms race from the ultimate infection and immunity perspective. However, besides the requisite molecular/gross
anatomical and physiological bases for infectious diseases to transmit from one host to another, both viral pathogens and their reservoirs/
vectors exploit a complex anthropological, cultural, historical, psychological and social suite that speciﬁcally deﬁnes the phylodynamics
within Homo sapiens, unlike any other species. Some of these variables include the ecological beneﬁts of living in groups, decisions on
hunting and foraging behaviours and dietary preferences, myths and religious doctrines, health economics, travel destinations, population
planning, political decisions on agricultural product bans and many others, in a homo-sociome memetic complex. Taken to an extreme,
such complexities elucidate the underpinnings of explanations as to why certain viral zoonoses reside in neglected people, places and
things, whereas others are chosen selectively and prioritized for active mitigation. Canine-transmitted rabies serves as one prime example
of how a neglected viral zoonosis may transition to greater attention on the basis of renewed advocacy, social media, local champions and
vested international community engagement. In contrast, certain bat-associated and arboviral diseases suffer from basic ignorance and
perpetuated misunderstanding of fundamental reservoir and vector ecology tenets, translated into failed control policies that only
exacerbate the underlying environmental conditions of concern. Beyond applied biomedical knowledge, epidemiological skills and
biotechnical abilities alone, if a homo-sociome memetic complex approach is also entertained in a modern transdisciplinary context,
neglected viral zoonosis may be better understood, controlled, prevented and possibly eliminated, in a more holistic One Health context.
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rights reserved.
Keywords: Conservation medicine, ecohealth, emerging infectious diseases, neglected tropical infections, one health, viral zoonoses
Article published online: 11 March 2015Clin
Cli
httCorresponding author: C.E. Rupprecht, The Wistar Institute, 3601
Spruce Street, Philadelphia, 19104, PA, USA
E-mails: charleserupprechtii@gmail.com, charles_rup-
precht@yahoo.comViral zoonotic underpinningsAll major human viral diseases once originated in other animal
species and formed unconnected prehistoric biological islands,
but now, new pathogens are being characterized at anMicrobiol Infect 2015; 21: 394–403
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.02.032unprecedented level with the potential for dramatic pandemics,
due both to ecological perturbations and to technological im-
provements in detection [1]. Nevertheless, at a recent inter-
national biomedical conference, one speaker reminded the
audience of the statistical ‘irrelevance’ of emerging infectious
diseases, by categorical comparisons to major causes of human
death today. Put simply, even populations in the developing
world are approaching levels of cardiovascular disease, stroke,
cancer and other chronic maladies, that were previously only
found in developed countries. Although this may certainly be
true, if an individual evades acute viral diarrhoea, pneumonia,
haemorrhagic fever, hepatitis, encephalitis, etc. and survives outious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Rupprecht and Burgess Neglected viral zoonoses 395of infanthood to adolescence, those more modern facets of
chronic illness are largely associated with a personal lifestyle
elevated gradually to a community level. In contrast, zoonoses
per se, are largely not a matter of conscious public choice,
although the exposures that lead to a productive infection are
often provoked directly by the individual. Irrespective of sur-
reptitious media bragging rights to causality behind any ﬁctitious
‘zombie apocalypse’ or its preparedness (http://www.cdc.gov/
phpr/zombies.htm; http://www.cracked.com/article_15643_5-
scientiﬁc-reasons-zombie-apocalypse-could-actually-happen.
html) in the growing collective consciousness (for which a
discerning scientiﬁc audience would have to ascribe not to
bacteria, fungi or protozoa, but to a viral aetiology objectively),
the image of a post-SARS world is only too real in the not-too-
distant memory, given the actual extremes of current global
headlines of translocated viral infections from one continent to
another. Moreover, regardless of the magnitude of long-term
lifestyle choices behind major human mortality trends, most
health professionals should agree that the probability would be
highly unlikely that a traveller today would be screened,
detained and possibly quarantined against their will at an in-
ternational port of entry, because of being a smoker, alcohol-
user or obese, as opposed to a suggestion of an infection
with a viral infectious aetiology, with obvious immediate con-
sequences for the perceived greater public good. Hence, many
would argue that viral zoonoses are indeed still relevant, based
upon the evidence at hand.
Why are viral zoonoses relevant, but neglected? Considering
the ultimate origins of historical pathogens as diverse as the
eradicated smallpox and the much debated 1918 pandemic
inﬂuenza, viruses are a highly relevant focus group when
considering the general concept of zoonoses as a whole, from
obvious biodiversity, to the sheer magnitude of their resultant
cumulative morbidity and mortality in the animal kingdom writ
large and the concomitant host–pathogen arms race [2]. Such
viruses are the quintessential obligate microbiological parasites,
whose diversity across all life on earth is unmatched. Rates of
evolution, particularly among RNA viruses, excel at real-time
orders of magnitude [3]. Antibiotics are useless, antiviral
drugs remain limited and proper discovery requires a requisite
twenty-ﬁrst century laboratory sophistication, relatively far
from the ecosystems where these zoonoses perpetuate, from
urban mega-slums to increasingly fragmented Old World rain
forests, supporting both viral specialists and generalists within
multi-host assemblages [4]. Within the ‘mind’s eye’, unlike
multicellular organisms and bacterial/fungal colonies, viral ex-
istence and growth are typically unseen and often asymptom-
atic. ‘Out of sight, out of mind’, in the sense of the virome, is
taken to an extreme from the perspective of neglect with most
viruses in the primary host, unless frank disease and mortalityClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyare manifest. To the evolutionary biologist, all extant human
viruses rose from more humble origins. Bereft from an
appreciation of animal ecology, viruses, by deﬁnition, are
neglected, in a circumspect fashion, and undergo a pattern of
subtle repetition over time (Fig. 1). What began as a largely
one-sided accident before animal domestication millennia ago
proceeds to a ‘reverse-zoonosis’ paradigm, as expanding inter-
connected human communities become the drivers back to
other animals, often with disastrous consequences for threat-
ened and endangered species [5].Critically ignored macroscopic attributesBroadly speaking, any RNA or DNA virus transmitted to a
human from a member of the Kingdom Animalia is open to
partitioning as a viral zoonosis. Of the hundreds of potential
viral candidates, what constitutes a ‘neglected viral zoonosis’
(NVZ)? To be considered a NVZ, a disease is not equivalent to
being merely odd or rare, objectively, from the stand point of
concentration, which does not diminish the public health
concern for any malady, per se. Hence, as one example, obvi-
ously simian herpesvirus is a serious viral infection, but not a
NVZ. Similarly, a NVZ does not necessarily mean that no di-
agnostics or vaccines or practical mitigation options exist or
that little is known about pathogen epizootiology. In fact,
ironically, many NVZ have pragmatic solutions for investigation,
prevention and control—exacerbating the overall philosophy
of neglect. Rather, operationally deﬁned subjectively, NVZ
should be associated with signiﬁcant ‘negative’ attributes,
including: substantive human morbidity and mortality; broad
distribution; serious economic costs; selective opportunity to
spread if ignored; a lack of concentrated long-term efforts
focused at the source; and a disproportionate burden on the
poor [6,7]. So deﬁned, most NVZ occur in developing coun-
tries with a subtropical to tropical occurrence.
To a ﬁnite extent, biomedical introspection related to entry,
reception, replication, transcription, assembly and exit from
one species to a human may provide a great deal of inference to
various NVZ. However, beyond the descriptive ‘who, what,
where, when and how’ of the original animal virion and the
secondary human host, these qualitative insights will always be
wanting to a greater epidemiological understanding of the ‘why
things are’. Ultimately, besides an anatomical and physiological
basis for a viral infection to transmit interspeciﬁcally, both
pathogens and their reservoirs/vectors must exploit a complex
anthropological, cultural, historical, political, psychological and
social landscape that uniquely deﬁnes Homo sapiens, unlike any
other animal population [8–12]. Some of these facets include
the ecological beneﬁts (and limitations) of living in groups as aand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 394–403
TABLE 1. Illustrations of various homo-sociome memetic
complex (HOSMEC) factors, which may inﬂuence
emergence and perpetuation of neglected viral zoonoses
Factor Example
Anthropological Domestication of certain wild taxa based on recognized utility
Cultural Perceptions of individual utility versus community animal
ownership
Economic Differential veterinary care/husbandry based on local value
systems
Educational Restriction to only certain groups based on multiple factors
Familial Intrinsic recognition of pets and interactions as family members
Historical Precedent of zoonosis control programmes irrespective of
evidence
Legal Animal welfare norms and protections or provisions as chattel
Occupational Degree of engagement is a traditional inheritance or open to free
choice
Philosophical Dietary choices from opportunistic to strict veganism unrelated
to health
Political Leadership determination of agro-policies, from tribal to national
Religious Interactions with particular species deemed taboo or unclean
Social Age, caste or gender bias to focal interactions dealing with animals
FIG. 1. Simpliﬁed historical composite and evolution of zoonotic viral infectious threads from simple linear dead-end spillover cases from wildlife, to
other eventual ampliﬁcation into domesticated species, to development of human pandemic states and reverse dynamic spread back among other non-
human wild or domestic species, using current examples (for example, although avian inﬂuenza may infect domestic poultry or humans, infected
humans can also infect domestic animals; similarly, while lyssavirus reservoirs are found among wildlife, rabid domestic dogs can infect wild carnivores).
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preferences, myths and religious doctrines, health economics
and many others, in a myriad of a homo-sociome memetic
complex (HOSMEC). Taken together, such an introspective
transdisciplinary approach serves to explain the ultimate suc-
cess or failure of a zoonosis programme and the basis of clues
as to why some NVZ collapse or persist. Moreover, in-depth
critical utilization of the HOSMEC idea may provide answers
as to why a NVZ may reach a certain critical tipping point to
ﬁnally receive focused attention among a myriad of outcomes,
because of humanitarian extension of a novel intervention from
applied research or due in part from a perceived threat to
impact non-enzootic developed countries (Table 1). The reality
of NVZ in situ is not as simple as a random meeting between
infectious non-human host X and susceptible human individual
Y, but predicated among populations by HOSMEC Z + N fac-
tors in space and time, as deﬁned broadly by the human–animal
bond (Fig. 1).
Using the HOSMEC concept as a backdrop, in this paper we
concentrate upon several NVZ that meet our criteria for in-
clusion, discuss strategies for future prevention and control and
draw upon the majority of supportive examples from the
recent peer-reviewed literature as to missed opportunities and
a way forward in the near term.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectThe incurable wound revisited as the major
NVZRecently, one major NVZ selected for greater attention by the
international community is human rabies transmitted by dogs,
also known as canine rabies, embraced by the triumvirate of
FAO (http://www.fao.org/news/story/en/item/198087/icode/),ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 394–403
TABLE 2. Common prevailing global rabies perceptions that
perpetuate a cycle of neglect and programme failure
Issues
Attitude – ‘It’s only rabies!’
Burden – ‘Few to no human fatalities measured’
Monitoring – ‘Just not enough animal cases to justify concern’
Responsibility – ‘Dogs are not a commodity’
Prevention – ‘Local biologicals are ineffective’
Control – ‘Culling will work for any outbreak’
Epizootiology – ‘Uncontrollable stray dogs are impossible to resolve’
Reservoirs – ‘Wildlife maintain infection cycles’
Economics – ‘Vaccines are not affordable’
Perpetuation – ‘Animals are true carriers’
Engagement – ‘Communities simply do not care’
Support – ‘No global partners exist’
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portal/) and WHO (http://www.who.int/neglected_diseases/
WRD_rabies_2013/en/) as a valuable public good, in the
mould of the One Health philosophy towards ‘No More Deaths
From Rabies’.
A number of pervasive myths served to illustrate the
HOSMEC spectrum as to why rabies languished as a NVZ
(Table 2), despite being one of the oldest zoonoses and having
the highest case fatality of any infectious disease. Simply put, a
strong deliberate track record of primary evidence coalesced as
counter HOSMEC facets to refute such arguments for pro-
grammatic obsolescence [13–24]. Unfathomably, some may
question the status of canine rabies as a NVZ, but the disease is
a bona ﬁde choice, considering that tens of thousands of people,
mostly children, succumb annually, tens of millions of human
exposures occur requiring intervention and all of the major
tools for elimination were present by the mid-twentieth cen-
tury [13,14,17]. By comparison with rinderpest, vaccination
towards herd immunity, sensitive and speciﬁc diagnostics and
the epidemiological knowledge to apply both to the ﬁeld were
comparable to an equally complex disease for decades [15,18].
Oddly, canine rabies still exists in a diagnostic cycle of neglect,
despite laboratory insights for conﬁrmation since the late
1800s, and is the only infectious disease in which a routine
diagnostic test applied to an animal directly determines the
need for medical intervention in the bitten person [17]. Clearly,
unlike beef, poultry, seafood and swine, dogs are not a con-
ventional market commodity, even if they are still consumed in
certain markets. As a result, rabies requires an inter-sectoral
approach among professionals for ultimate success [13,20,23].
Inarguably, modern human and veterinary biological agents
against rabies are pure, potent, safe, efﬁcacious and inexpensive,
considering the alternative outcome of a productive encepha-
litic infection [16,17,20]. Long-term lethal culling of dogs has
not been demonstrated to be an ethically supported, ecologi-
cally based or economically sound strategy to control canine
rabies [19,20]. By contrast, in both the New and Old Worlds,Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyherd immunity is achievable among dynamic canine populations
[13,15,20]. Although a plethora of wildlife reservoirs maintain a
diversity of other rabies virus variants, their existence in
developed countries was not a barrier to canine rabies elimi-
nation and oral vaccination has proven to be a successful
intervention towards a holistic programme approach, when
mesocarnivore populations are determined to be important
[21]. Although often used as an epidemiological ploy to explain
programme failure or to save face, no true rabies virus carriers
have been documented [22]. Substantively, rather than indeﬁ-
nite reliance upon outside economic aid, community engage-
ment and social responsibility are a longer-term strategy for
programme perpetuation [23]. Another HOSMEC facet to
counter naysayers is a designated date for global action (http://
rabiesalliance.org/world-rabies-day/) and the international
partnering that has evolved among dedicated academic, gov-
ernment, industrial and non-governmental organization stake-
holders, who champion the advocacy, communication,
education and research towards canine rabies elimination as a
realistic cause célèbre [24].
Besides canine rabies as the epitome of a NVZ and the related
HOSMEC applications as background narrative, in consideration
of other potential viruses, a divergent ecological and evolu-
tionary perspective can be assumed, as regards potential path-
ogens and vectors. That is, are there particular major animal
hosts that are contenders for discussion? Within the verte-
brates, there are no serious NVZ candidates among the ﬁsh,
amphibians and reptiles. Arguably, with the exception of the
‘avian inﬂuenza mixing milieu’ (which is not truly neglected by
our above subjective criteria and the considerable budgets
available for basic and applied research), no major NVZ are
based among the birds. Concentrating upon mammals, with
degrees of genetic relationship closest to Homo sapiens, one
might be tempted to consider viral pathogens associated with
non-human primates. However, unless considering the evolu-
tionary and epidemiological relationships of the simian retrovi-
ruses (notwithstanding the consequent radiations that led to
human immunodeﬁciency virus) and their related viral spectrum
(which also do not ﬁt the criteria of NVZ), the non-human
primates are twenty-ﬁrst century evolutionary bottlenecks,
geographically isolated and largely not in temporal/spatial prox-
imity to most people. This limitation does not apply to other
relevant and highly misunderstood mammals—the Chiroptera.Bats and NVZMany of the recent NVZ have been due to human and domestic
animal interactions with wildlife and of these, several prominent
examples have been associated with bats (Table 3). Bats are notand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 394–403
TABLE 3. Selected neglected bat-associated viral zoonoses
[25–32]
Example Taxa Distribution Comment
Lyssaviruses Rhabdovirus Global Thousands of annual deaths
Ebola/Marburg Filovirus Africa, Asia Pandemic potential?
Henipah Paramyxovirus Austral-Asia Human–human possible
SARS/MERS Coronavirus Asia/Middle East Human–human likely
Menangle Paramyxovirus Australia Human infection, no deaths
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associated viral diseases as a single complex pertains to the
biological attributes applied objectively to these species as a
whole, in a special status [25]. Compared with human and
domestic animal populations, wildlife have always been noto-
riously more difﬁcult to study. Bats are no exception. As
typically smaller, inconspicuous, volant animals, relatively less is
known about this group than other mammalian taxa. As the
second largest mammalian Order, with over 1000 species, their
abundance, distribution, biodiversity and lifestyle collectively
provide a complication when trying to infer overarching ele-
ments from epidemiological insights to prevention and control
strategies over their collective virome, as exempliﬁed by
numerous NVZ [26–31]. Besides prominent scientiﬁc neglect
until the mid-twentieth century, bats have been reviled in many
cultures as concerns the HOSMEC principle, despite their
obvious utility as the only prominent nocturnal predators of
agricultural insect pests and by the ecological services they
provide through pollination and reforestation from seed
dispersal, which is often forgotten when weighing zoonotic
risks in a conservation biology perspective [32].
From a global and zoological perspective, the overwhelming
majority of bats require no special consideration for human or
domestic animal health. Rather, distribution of the few docu-
mented NVZ among the Chiroptera is highly uneven. Major
genera appear somewhat restrictive based upon surveillance to
date, including: Artibeus, Desmodus, Eidolon, Eptesicus, Hippo-
sideros, Lasiurus, Lasionycteris, Myotis, Perimyotis, Pteropus, Rou-
settus and Tadarida. Interspeciﬁc transmission may be direct,
especially in the case of the bat lyssaviruses (such as vampire-
transmitted rabies), but often may involve an intermediate
mammalian host for ampliﬁcation: insectivorous bats and civets
in the night markets of Asia for SARS; Old World bats and non-
human primates and bushmeat exposures for Marburg/Ebola
viruses; fruit bats and horses for Hendra virus; pteropid bats
and swine for Nipah and Menagle viruses; various bat species
and camels for Middle East respiratory syndrome [26–31].
Besides long-term occupational alternatives for bushmeat
acquisition, practices to limit the inappropriate harvesting and
mixing of wild mammals for human consumption, curbs on
habitat encroachment and degradation, among others, anClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectintermediary link of domestic animals with the bat-associated
NVZ offers a benchmark for development and application of
relevant veterinary vaccines, as appropriate. Given these
comparative points, and the recent ﬂurry of attention over
Ebola, a decade from now may be an appropriate time span to
review the status of the ﬁloviruses as a whole and their gradual
rise to NVZ status and beyond, either towards ascendency
approaching avian inﬂuenza in prominence or fading to obscu-
rity with the other bat zoonoses.
Selected continent-jumping mosquito-
transmitted NVZ: dengue, chikungunya and
Zika virusesBesides mammals, many viral arthropod-borne contenders
meet the criteria of NVZ, considering the myriad of agents
transmitted to humans by invertebrates. Among the Arthro-
poda, ticks and insects are the two major representatives, and
of the latter, given the mobility offered by ﬂight (like bats and
birds), the mosquitoes are highly effective vectors. Currently,
there are at least three different species of arboviruses (dengue
virus (DENV), Chikungunya virus (CHIKV) and Zika virus),
transmitted predominantly by common vectors, the Aedes
mosquitoes, that present similar syndromes and produce
rapidly advancing outbreaks, mainly in developing tropical
countries. Regardless of the large number of potentially infected
individuals and the massive burden these infections pose on
local economies, they remain largely ignored. Moreover,
despite the emphasis placed on these emerging diseases by
organizations such as the WHO, these NVZ are continuing to
evolve. Ensuing concomitant human outbreaks are becoming
much more frequent. Historically operative and ecologically
naive HOSMEC are partly to blame. Not the least of these are
referential to the geographic foci of these NVZ and the
forgotten opportunities presented by the management of
malaria and yellow fever in developed countries, combined with
the daily success offered by air conditioning on demand, win-
dow screens, insect repellents and environmental mitigation
practiced in an ecologically sound philosophy of Western civi-
lization, which naively assumes homogeny abroad.
Prominent arboviral taxa operative among the NVZ
As prominent viral examples, among the Flaviviridae, the genus
Flavivirus includes at least 53 recognized species, of which many
are human pathogens. These viral species cluster into ecologi-
cally distinguishable groups. Sequence analysis provides grouping
into distinct lineages that correspond closely to the arthropod
groups responsible for transmission. Additionally, the mosquito-
borne ﬂaviviruses can be grouped further into a Culex group andious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 394–403
CMI Rupprecht and Burgess Neglected viral zoonoses 399an Aedes group. The tick-borne ﬂaviviruses (and the ﬂaviviruses
with no vector) cluster into another genetic group. Within the
Aedes group are four important clusters: the yellow fever group;
the Entebbe virus group; the DENV group (including DENV 1 to
4); and the Spondweni virus group, that includes Zika virus [33].
Recognized as a continuing global threat, more than 2.5
billion people are estimated to be at risk of DENV infection,
with 975 million people living in urban areas in South-East Asia,
the Paciﬁc and the Americas [34]. Less known than DENV, Zika
virus was ﬁrst isolated in Uganda during 1947, with a natural
transmission cycle involving mainly vectors of the Aedes genus
and non-human primates, with occasional infection of humans.
During 2007, Zika virus was responsible for an epidemic in the
Federated States of Micronesia, including the island of Yap [35].
Thereafter, during 2013, the ﬁrst cases were reported in
French Polynesia. This recognition was followed by outbreaks
in New Caledonia, the Cook Islands, Easter Island and now
almost certainly will spread to other Paciﬁc islands [36].
In contrast to the above Aedes-transmitted ﬂaviviruses,
CHIKV is a member of the family Togaviridae, genus Alphavirus.
Within Africa, CHIKV circulates in an enzootic cycle involving
forest-dwelling mosquitoes and non-human primates. The agent
was ﬁrst isolated in Tanzania during 1953 from the blood of a
febrile person during a large outbreak of a disease characterized
by severe fever and crippling joint pains (giving CHIKV its name,
literally ‘bent over’). Out of Africa, CHIKV was isolated during
1958 from a patient in Bangkok. Sporadic outbreaks were re-
ported in numerous African and Asian countries for decades and
then during April 2005, CHIKV was conﬁrmed as the cause of an
epidemic of dengue-like illness on the Comoros islands off the
east coast of northern Mozambique. Shortly after this outbreak,
the disease was reported on Mayotte, Mauritius and the French
island of La Réunion [37]. During December 2003, CHIKV was
detected in the FrenchWest Indies. The virus has spread rapidly
tomany otherCaribbean islands, aswell as to South America, and
poses a signiﬁcant threat to bothNorthAmerica andEurope [36].
Morbidity associated with Aedes-transmitted
arboviruses
The DENVs produce several syndromes that can be affected by
host age and immunological status. Most children experience
subclinical infection or mild febrile syndromes. Symptoms and
signs include fever, malaise, headache, body pains (break-bone
fever) and a rash. Some cases may progress to severe dengue in
which there can be bleeding, thrombocytopenia, ascites,
continuous abdominal pain, restlessness, persistent vomiting
and a sudden reduction in temperature. Severe dengue is more
likely to occur when a patient is infected with a second or third
case of dengue. There can be substantial differences in the
pathogenicity of different strains of virus as well as individualClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologydifferences in the susceptibility of patients. Previous infection
with DENV may be protective to some extent or it may
exacerbate the condition [34].
Today, CHIKV is considered to be one of the members of
the arthritic alphaviruses, most of which are in the Semliki
Forest group. These include Ross River virus, O’nyong-nyong
virus and Mayaro virus. The most frequent signs and symptoms
include fever, rash, myalgia with arthralgia or arthritis. There
may also be fatigue, tenosynovitis, headache, nausea, oedema,
vomiting, conjunctivitis and occasional bleeding gums and
epistaxis. As apparent to practitioners, a clinical diagnosis of
CHIKV infection is complicated, because of the very similar
presentation to DENV infection [38].
Similarly, the clinical presentation of Zika virus infection is
often described as ‘dengue-like’ with signs and symptoms
including arthralgia, oedema of extremities, mild fever, head-
ache, retro-orbital pain, conjunctival hyperaemia and mac-
ulopapular rashes, usually spreading downward from the face to
the limbs and is frequently pruritic. Additionally, there may be
vertigo, myalgia and digestive disorders [39]. During a recent
outbreak in French Polynesia, a cluster of patients presented
with a Guillain-Barré syndrome that appeared to correlate with
disease occurrence [40].
Evolution of the arboviral NVZ
Unlike a well known NVZ such as rabies, one of the basic
HOSMEC issues associated with DENV, CHIKV and Zika virus
are the previous historical limitations to the subtropical regions,
where most Europeans and North Americans never encoun-
tered them. In contrast to the other two arboviral NVZ, the
DENVs have a long history of human infection, with docu-
mented cases of a disease resembling dengue (meaning cramps,
seizures, or stiff-gait) as early as the third century. In the late
1700s there appears to have been a widespread geographical
distribution of dengue that coincided with the increasing global
commerce aided by sailing ships. A second series of dengue-like
pandemics were subsequently reported from Africa to India to
Oceania and the Americas from 1823 to 1916. Following the
Second World War and the dramatic increase in urbanization,
with inadequate housing and water distribution systems, the
vector Aedes aegypti reached high densities, facilitating the efﬁ-
cient transmission of DENV. Four antigenically distinct sero-
types of DENV are recognized at present. In all four cases the
transmission of DENV includes a sylvatic, enzootic cycle be-
tween non-human primates and arboreal mosquitoes of the
genus Aedes. This has led to distinct emergence events pre-
sumably involving host shifts from arboreal Aedes mosquitoes to
Aedes albopictus and later to Aedes aegypti [41].
As the four serotypes of DENV have further evolved, it
appears reasonable to regard these as four distinct viraland Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 394–403
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butions. Furthermore, within each serotype, distinct clusters of
viral strains have been recognized. This was initially achieved
through RNA ﬁngerprinting and with the advent of RT-PCR and
Sanger sequencing, with additional information on envelope
gene sequences, substantial amounts of epidemiological data
were produced. With the introduction of next-generation
methods, full-length sequencing is rapidly replacing the char-
acterization of single genes and provides a better understanding
of the distribution of dynamic quasispecies [41].
The ancestral sylvatic DENV transmission cycles still exist,
maintained in the forests of South East Asia and West Africa.
Conditions required for the adaptation of these viruses to
humans remain operative. Continued spillover and emergence
into human populations is likely to occur with strains that are
substantially different to those presently circulating, giving rise
to further epidemics [42].
In contrast to DENV, CHIKV in Africa evolved with two
enzootic lineages. Estimates place introduction into Asia
approximately 70–90 years ago. The recent Indian Ocean and
Indian subcontinent introductions of CHIKV emerged inde-
pendently from the east coast of Africa [43]. Currently, three
genotypes of CHIKV are recognized as Asian, East Central
South African and the West African. The isolates recognized
recently in the Caribbean are within the Asian genotype and
closely related to strains recently isolated in China and the
Philippines. The two isolates recently obtained from Yap, the
British Virgin Islands, China and the Philippines form a separate
clade within the Asian genotype [44].
Paralleling the translocations of DENV and CHIKV, there have
been at least two independent introductions of Zika virus from
the Zika Forest region of Uganda into West Africa during the
1950–60s. During the 1940s, Zika virus was introduced into
Malaysia and then onto the Paciﬁc Islands [35]. A high serological
prevalencewas noted inNigeria during 1979 and in the late 1970s
in Indonesia a prevalence of 7.1% was noted. An epidemic has
been described in French Polynesia since October 2013 [39].
Following this latter focus, there were subsequent outbreaks in
New Caledonia, the Cook Islands and Easter Island [40]. As Zika
virus is transmitted by the samemosquitoes asDENV andCHIKV
and the clinical signs are relatively similar, there could be sub-
stantial incursions in countries where these viruses are already
endemic (such as in the Caribbean region), without being readily
detected, given the paucity of laboratory-based surveillance.Economic impactsAccurate and comprehensive studies that outline the economic
and health burdens of most NVZ are relatively sparse, butClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectappear dire when attempted. For example, an estimate of mean
health costs of hospitalization in South America for a case of
DENV was ~US$571. One estimate of the annual global burden
was 750 000 disability-adjusted life-years. An extrapolation of
the annual cost of DENV across the Americas (2000–2007)
was US$2,149.8 [45,46].
In many countries, the burden of DENV is under-reported,
as a number of cases are subclinical and in addition the re-
sources available for collecting data are often restricted to
government health workers and hospitals. Many of the patients
present to private practitioners, who do not have any incen-
tive to report the cases. As CHIKV may have a lower per-
centage of subclinical cases, the reporting may reﬂect a slightly
more accurate assessment. Unfortunately, most of the esti-
mates fail to take into account the cost of providing vector
monitoring and control, and to address all of the additional
costs, such as education and lost work days. Signiﬁcantly, many
of the countries where these viruses are endemic, or coun-
tries facing epidemics, derive much of their income from
tourism. Regardless of the direct impact upon the service
sector itself, if a country earns a reputation as an unsafe
destination, this would have devastating effects on the tourism
industry overall, as a notable HOSMEC incentive towards
under-reporting.
By comparison, in the CHIKV outbreak on the island of La
Réunion, more than one-third of the 800 000 inhabitants were
infected, with an estimated productivity loss of V17.4 million
and medical costs of V43.9 million. However, the cost of
sequential or concurrent infections with DENV, CHIKV and
Zika viruses is unknown [47]. Given the clinical impact, there is
an urgent need for additional comprehensive research that
reﬂects the true cost of these collective NVZ and to support
vaccination and control programmes [45].NVZ extrapolation—transmission by blood
transfusionsIf a person is affected unknowingly by a NVZ, organs, tissues or
ﬂuids may be infectious and pose risks for an opportunistic
infection. For example, blood collected from arboviraemic
patients could be responsible for transfusion-transmitted in-
fections. A survey of Zika virus in donated blood samples in
French Polynesia found 2.8% reactors. High rates of asymptom-
atic infections are a major concern and arbovirus transfusion-
transmitted infections have been reported for West Nile virus,
DENV andCHIKV.During the outbreaks ofCHIKV in Italy during
2007 and in La Réunion 2005–2007, products were imported
from blood banks elsewhere. However, this is not an option in
most affected developing countries [48].ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 394–403
CMI Rupprecht and Burgess Neglected viral zoonoses 401Threats to non-endemic areasOne of the major concerns behind an interest in NVZ is the
risk these aetiological agents and vectors pose to unaffected
areas. Large areas of southern Europe, the southern USA and
the northern parts of Australia, as well as the subtropical re-
gions of southern Africa and South America, have been colo-
nized by Aedes aegypti and Aedes albopictus is continuing to
invade a number of these areas. Aedes albopictus is able to
survive at lower temperatures than Aedes aegypti and is less
dependent on the urban environment with man-made con-
tainers. With the rapid movement of viraemic individuals and
the potential of subclinical or unapparent infections, the pos-
sibility of transmission of one or all of these viruses is relatively
high. If there is a stable population of a suitable vector,
autochthonous transmission remains a genuine possibility
[36,49].Serious prospects for human vaccination?Unlike rabies, development of safe, efﬁcacious and affordable
human vaccines for the arboviral NVZ have lagged. However,
efforts to develop effective DENV vaccines have signiﬁcantly
increased over the last decade, and a wide range of vaccine
approaches is under current evaluation, largely due to military
interests [50]. Regardless of initial proof of concept, such vac-
cines will need to be tailored to the national requirement of the
target countries. Measurement of efﬁcacy may be difﬁcult,
especially where subclinical infections are common and the
infrastructure for monitoring infection is limited. Antibody-
dependent enhancement must not occur in the ideal vaccine
candidate and clinical trials must closely monitor the appear-
ance of any such adverse events. To implement any vaccination
programme, appropriate cost–beneﬁt analyses are highly
desirable. Despite their inherent importance, very few such
analyses have been produced to date [46].
Effective vaccines for CHIKV are much more limited than
DENV, with no prospect for rapid implementation. Similarly,
considering that Zika virus only affects individuals in developing
countries, the incentive for any investment in vaccine studies is
almost non-existent.Continued emergence of highly
opportunistic vector speciesNew sylvatic cycles frequently rely on host shifts and vector
species that are not currently involved in the transmission andClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologymaintenance of these NVZ. Bats, mesocarnivores, rodents and
arthropod vectors are highly successful as invasive taxa. These
vector species may have the potential to be transferred to
other locations, where they can thrive. For example, in some
limited areas, there have been additional species responsible for
the transmission of CHIKV and Zika viruses. Relocation of
these vector species may be likely, especially with impending
climate change scenarios. Given the reality of modern global-
ization, these vector–virus translocations are becoming a
routine event.Challenges in the monitoring, prevention and
control of NVZA holistic appreciation of the ecology of infectious diseases
should provide solutions towards practical interventions.
Clearly, from the rapid and ongoing increase in prevalence of
these highlighted neglected taxa, control measures presently
being used are ineffective. However, in some resource-poor
environments, it may be possible to at least monitor the
presence and relative abundance of insect vectors as a start, if
technical staff with the requisite knowledge, skills and abilities
are nurtured appropriately. Nevertheless, implementation of
effective control programmes appears to be beyond the scope
of the present resources. Some future innovative control
programmes may have the potential to make a difference in
regions where only one mosquito is the sole vector, but similar
approaches have yet to be successful with all potential vectors
and NVZ pathogens.
Prevention by vaccination would require a high level of hu-
man herd immunity and is likely to be only successful if applied
as part of a very integrated approach using vector control and
education to supplement such vaccination.
Vector management is an integral part of the control of any
NVZ. Signiﬁcantly, during the 1960s, a campaign to eradicate
Aedes aegypti from South America had a dramatic inﬂuence on
the transmission of DENV. When this campaign was aban-
doned, there was a massive increase in vector abundance that
contributed signiﬁcantly to the high rates of DENV infection
today [51]. Even greater challenges are posed with Aedes albo-
pictus [52,53]. An integrated One Health programme should
engage community participation in vector control, including
elimination of larvae by reducing potential breeding containers
and treatment with larvicides, insecticidal spraying, especially
targeted spraying in potential resting areas (fogging with large
amounts of insecticide has minimal effect when it fails to reach
the target insects) and biological control using larvivorous or-
ganisms or bioinsecticides. There is potential opportunity in
environmental release of genetically modiﬁed insects, includingand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 394–403
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be developed for Aedes albopictus [52,53]. Additionally, the
implementation of autocidal gravid ovitraps may substantially
reduce the populations of vectors [54]. Post-application, vector
monitoring is an extremely useful tool and is absolutely
essential to direct effective control programmes and to gauge
success.ConclusionsViral zoonoses span a gamut from widespread global distribu-
tions and dramatic human mortality to more chronic perpet-
uation and existence in relative obscurity. Rabies, the bat-
associated viral zoonoses and the arthropod-borne viruses
transmitted by Aedes mosquitoes provide a contrasting pano-
ramic cross-section of the opportunities and challenges posed
by such concomitant NVZ in economically disadvantaged
tropical regions. By historical illustration, as one of the oldest
appreciated infectious diseases, canine-transmitted rabies is the
epitome of a NVZ, with a strong probability for continued
success in substantial prevention, control and elimination over
the next 10–20 years. In contrast, although the bat-associated
zoonotic viruses have received increasing attention over the
last decade and appear to be emergent for similar reasons
regardless of viral pathogen, there are no major options for
vaccine intervention at the wildlife source, in comparison with
canine rabies. Considering arboviruses, the DENV, CHIKV and
Zika viruses represent a similar clinical syndrome in toto and
may obfuscate surveillance and appropriate medical response,
yet more simpliﬁed monitoring systems and mitigation focused
upon the primary mosquito vectors should be advantageous, in
lieu of available human vaccination.
Besides these selected examples of NVZ, additional salient
representatives could have included Rift Valley fever, the
rodent-associated zoonoses such as the hantaviruses, hepatitis
E virus, tick-borne encephalitis and multiple others. Never-
theless, regardless of pathogen or vector, consideration of all of
the NVZ (as well as other non-viral agents) in a One Health
context is the best option for a community-based approach to
the long-term detection of, response to and mitigation of
zoonoses as an integrated unit, rather than as an individual
agent or disease [55]. Finally, beyond the classical microbio-
logical and biomedical aspects of human, veterinary and con-
servation medicine, the basic underpinnings to these neglected
entities are often more deeply rooted in a complex suite of
anthropological, cultural, religious and social factors, which also
may persist or change abruptly over time as the agents and
vectors in kind. Failing to appreciate such a transdisciplinary
HOSMEC milieu may do little to alter the history associated inClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectthe complex causality at the root of zoonotic disease emer-
gence and perpetuation, within the evolutionary play on an
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